D-FI
Live / Allowed — Notice of allowance issued (as of 23 Dec 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 13 May 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99182363
- Mark type
- Stylized text
- Filed
- 13 May 2025
- Published for opposition
- 28 Oct 2025
- Attorney of record
- Elizabeth M. O'Donoghue
Goods and services
- Class 005 — Pharmaceuticals: gene therapy products, namely, genetically modified cells for medical use for the treatment of dystrophic epidermolysis bullosa; pharmaceutical preparations and injectable biological preparations containing genetically modified materials for treatment of dystrophic epidermolysis bullosa; pharmaceutical preparations and therapeutic preparations for treatment of skin diseases, connective tissue diseases, arthritis and autoimmune diseases
Owner
- Castle Creek Biosciences, LLC, Exton, PA, US
- Castle Creek Biosciences, LLC, Exton, PA, US
Prosecution history
- 23 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Oct 2025 — PUBLISHED FOR OPPOSITION
- 22 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Sept 2025 — ASSIGNED TO EXAMINER
- 13 May 2025 — APPLICATION FILING RECEIPT MAILED
- 13 May 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 May 2025 — NEW APPLICATION ENTERED